日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Polyamine metabolism related gene index prediction of prognosis and immunotherapy response in breast cancer.

多胺代谢相关基因指数预测乳腺癌的预后和免疫治疗反应

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1613458
Wang Ruoya, Cai Shouliang, Gao Qing, Chen Yidong, Han Xue, Shang Fangjian, Liang Chunyan, Zhu Guolian, Chen Bo
代谢
乳腺癌
发表日期：2025
文献求助 收藏

Accumulated cytotoxicity of CDK inhibitor dinaciclib with first-line chemotherapy drugs in salivary adenoid cystic carcinoma cells

CDK抑制剂dinaciclib与一线化疗药物在涎腺腺样囊性癌细胞中的累积细胞毒性

期刊:Odontology
影响因子:1.9
doi:10.1007/s10266-019-00451-5
Laijun Xu, Lingzhi Li, Jun Zhang, Wenping Cai, Shouliang Zhao, Shangfeng Liu
肿瘤
肿瘤细胞
发表日期：2020
文献求助 收藏

Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy

新辅助化疗后三阴性乳腺癌中iNOS水平的临床意义

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0130286
Jin, Zining; Wang, Wenqian; Jiang, Nan; Zhang, Lei; Li, Yiming; Xu, Xiaoyin; Cai, Shouliang; Wei, Liang; Liu, Xuhong; Chen, Guanglei; Zhou, Yizhen; Liu, Cheng; Li, Zhan; Jin, Feng; Chen, Bo
肿瘤
肿瘤免疫
乳腺癌
iNOS
发表日期：2015
文献求助 收藏

CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6

CDK抑制剂p57（Kip2）受COP9信号体亚基6的负调控。

期刊:Cell Cycle
影响因子:3.4
doi:10.4161/cc.22887
Chen, Bo; Zhao, Ruiying; Su, Chun-Hui; Linan, Monica; Tseng, Chieh; Phan, Liem; Fang, Lekuan; Yang, Heng-Yin; Yang, Huiling; Wang, Wenqian; Xu, Xiaoyin; Jiang, Nan; Cai, Shouliang; Jin, Feng; Yeung, Sai-Ching J; Lee, Mong-Hong
信号转导
发表日期：2012
文献求助 收藏